Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 66937 [2013-26635]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Place: This meeting is accessible by Web
conference. Toll-free +1 (866) 844–9416,
Participant Code: 2727032.
For Participants:
URL: https://www.mymeetings.com/nc/
join/.
Conference number: PW5636201.
Audience passcode: 2727032.
Participants can join the event directly at:
https://www.mymeetings.com/nc/
join.php?i=PW5636201&p=2727032&t=c.
Status: Open to the public limited only by
web conference.
Participation by Web conference is limited
by the number of 100 ports available.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items
include the following topics: (1) ACET
Chair’s report to the Secretary; (2) ACET
Essential Components Workgroup Update; (3)
Drug Shortages Update; and (4) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton Road,
NE., M/S E–07, Atlanta, Georgia 30333,
Telephone: (404) 639–8317; Email: zkr7@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
Notice will be provided if the meeting
is rescheduled in accordance with
section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463).
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
Contact Person for More Information:
Joan F. Karr, Ph.D., Scientific Review
Officer, CDC/NIOSH, 1600 Clifton Road,
Mailstop E–74, Atlanta, Georgia 30333,
Telephone: (404) 498–2506. The
Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26650 Filed 11–6–13; 8:45 am]
[FR Doc. 2013–26633 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Notice of Cancellation: This notice
concerns ‘‘Occupational Safety and
Health Training Project Grants (T03),
Funding Opportunity Announcement
PAR–10–288, initial review, published
in the Federal Register on October 2,
2013 (FR Volume 78, Number 191, Page
60877). This SEP, scheduled to convene
on November 6, 2013, is canceled.
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Capacity Building Assistance
for High Impact HIV Prevention,
Funding Opportunity Announcement
(FOA) PS14–1403, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
66937
Times and Dates: 8:00 a.m.–8:00 p.m.,
December 10–12, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Capacity Building Assistance
for High Impact HIV Prevention’’ FOA PS14–
1403.
Contact Person for More Information:
Harriette A. Lynch, Public Health Analyst,
CDC, 1600 Clifton Road, NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
718–8837. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26635 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Occupational Safety and
Health Training Project Grants (T03),
PAR–10–288, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:00 p.m.–5:00 p.m.,
January 8, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Occupational Safety and Health
Training Project Grants (T03), PAR–10–288.’’
Contact Person for More Information: Joan
F. Karr, Ph.D., Scientific Review Officer,
CDC/NIOSH, 1600 Clifton Road, Mailstop E–
74, Atlanta, Georgia 30333, Telephone:
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Page 66937]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26635]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Capacity Building Assistance
for High Impact HIV Prevention, Funding Opportunity Announcement (FOA)
PS14-1403, Initial Review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned SEP:
Times and Dates: 8:00 a.m.-8:00 p.m., December 10-12, 2013
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Capacity Building Assistance for High Impact HIV
Prevention'' FOA PS14-1403.
Contact Person for More Information: Harriette A. Lynch, Public
Health Analyst, CDC, 1600 Clifton Road, NE., Mailstop E07, Atlanta,
Georgia 30333, Telephone: (404) 718-8837. The Director, Management
Analysis and Services Office, has been delegated the authority to
sign Federal Register notices pertaining to announcements of
meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-26635 Filed 11-6-13; 8:45 am]
BILLING CODE 4163-18-P
